<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0410538" disease_type="Disease or Syndrome" abbrv="PSACH">Pseudoachondroplasia</z:e> is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0029422" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">osteochondrodysplasia</z:e> characterized by <z:hpo ids='HP_0003498'>disproportionate short stature</z:hpo>, <z:hpo ids='HP_0001388'>joint laxity</z:hpo>, and early <z:hpo ids='HP_0003674'>onset</z:hpo> <z:mp ids='MP_0003560'>osteoarthrosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0410538" disease_type="Disease or Syndrome" abbrv="PSACH">Pseudoachondroplasia</z:e> is caused by mutations in the gene encoding cartilage oligomeric matrix protein (COMP) </plain></SENT>
<SENT sid="2" pm="."><plain>We looked for mutations in the COMP gene in three <z:hpo ids='HP_0003745'>sporadic</z:hpo> Chinese <z:e sem="disease" ids="C0410538" disease_type="Disease or Syndrome" abbrv="PSACH">pseudoachondroplasia</z:e> patients and identified two novel mutations, c.1189G&gt;T (p.D397Y) and c.1220G&gt;A (p.C407Y), and one recurrent mutation, c.1318G&gt;C (p.G440R), in the calcium binding type III repeats of COMP </plain></SENT>
<SENT sid="3" pm="."><plain>This study confirms the relationship between mutations of the COMP gene and clinical findings of <z:e sem="disease" ids="C0410538" disease_type="Disease or Syndrome" abbrv="PSACH">pseudoachondroplasia</z:e>; it also provides evidence for the importance of the calcium binding domains to the functioning of COMP </plain></SENT>
</text></document>